Scale's Brooks Looks Forward to 2010
Mark Brooks has been battling a minor cold. But when talking about health, it’s not his own that gets him fired up. Brooks, managing director of Scale Venture Partners, talked to me today about healthcare investing. Despite the sniffles, overall, I’d say he is optimistic about the industry. He admits there are challenges that lie ahead, but he says that “the fundamentals of our business is good.” And why wouldn’t he be excited about the new year? Alimera Sciences, one of two ophthalmology companies that the Foster City, Calif.-based firm has backed, is in registration for an $80 million IPO. And Brooks says he sees plenty of opportunities to find deals with good valuations. Brooks and I also chatted about health care reform and the 28th annual J.P. Morgan Healthcare Conference that launches next week. Q&A after the jump...
